EGFR and non-small cell lung carcinoma: By enhancing dendritic cell function, activating T cells and NK cells, suppressing immunosuppressive cells, and regulating cytokines, the integration of Lingzhi into existing therapies could enhance immune responses, reduce resistance, and improve clinical outcomes for patients with EGFR-mutated NSCLC [11,109,113].